The nomograms predicted overall and progression-free survival.
The results raise concern about potential local tumor spill, according to researchers.
Patients with parathyroid carcinoma after localized resection for a presumed benign indication should undergo close monitoring for recurrence rather than radical surgery.
The current scientific evidence may not be generalizable to underrepresented groups.
Immune-related adverse events were associated with improved survival outcomes.
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
Looking at single year of age revealed “substantial” differences.
A detailed smoking history may help to inform patient outcomes.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Efficacy differed by cancer type and KRAS status.
